Figure 1. Figure 1. Chemical structures of inhibitors (a) purvalanol A and (b) CGP77675 used for co-crystallization.
The above figure is reprinted by permission from Elsevier: J Mol Biol (2005, 353, 222-231) copyright 2005.
